US And EU Systems For Personalized Medicine: Paths Diverging?

There are changes afoot in the regulation and reimbursement policy for IVDs in the EU and US. When it comes to personalized medicine, and companion diagnostics in particular, are the two markets becoming more polarized? Medtech Insight asked US- and EU-based attorneys at Hogan Lovells.

IV1703_Medicine Gets Personal_1200x675

Changes in the regulation of IVDs in Europe could result in growing differences between how the EU and US regulate personalized medicine, including companion diagnostics. That is the view of Hogan Lovells' US-based life-sciences and health-care partner, Randy Prebula.

Prebula, who focuses on US FDA device and IVD issues, said in an interview with Medtech Insight that there is already quite a distinction between the EU and US regulatory...

Where Things Stand

IVDs play a key role in personalized medicine in assessing the genetic make-up of a patient to help ensure the selection of the best drug or other therapies for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from In Vitro Diagnostics

More from Diagnostics